Trial Profile
A pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2020
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms ASSertID; ASSertID-Phase 1; ASSertID-Phase2; ASSertID-Phase3
- 07 Jul 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record 14560.(ASSertID Phase 2)
- 26 Jun 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record 14415 (ASSertID Phase 1)
- 21 May 2015 Accrual to date is 160% according to United Kingdom Clinical Research Network record 14561 (ASSertID Phase 3)